Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1107421 · TCRT

Alaunos Therapeutics, Inc.

Filing with the SEC — delisting notice SEC-reporting company Fort Lauderdale, FL Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Oct 21, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Net loss in 2025Net loss of $4.2M for the year (2024: −$4.7M).
  • Revenue downRevenue fell from $10K in 2024 to $5K in 2025 (50% lower).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$5K$10K
Net income (loss)−$4.2M−$4.7M
Total assets$3M$2.8M
Total liabilities$813K$692K
Stockholders’ equity$2.2M$2.1M
Cash and equivalents$1.4M$1.1M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Alaunos Therapeutics, Inc.
Formerly: Ziopharm Oncology Inc
CIK
0001107421
Tickers
TCRT
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC — delisting notice
State of incorporation
Delaware
Business address
Fort Lauderdale, Florida
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Jun 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Oct 9, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01, 9.01 · filed Oct 21, 2026 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Oct 15, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 3.02, 5.02, 5.03, 7.01, 9.01 · filed Oct 13, 2026 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 3.02, 5.02, 5.03, 7.01, 9.01 · filed Oct 13, 2026 · filing
  • Notice from the exchange: Nasdaq · stockholders' equity
    Form 8-K · items 3.01 · filed Oct 9, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 15, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Apr 15, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 31, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 14, 2025 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Oct 30, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Oct 22, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 14, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 22, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jul 17, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 3.01, 5.02 · filed Jul 2, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01, 5.02 · filed Jul 2, 2025 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Jul 1, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 15, 2025 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed May 14, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Apr 18, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Apr 15, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01, 8.01 · filed Apr 11, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 31, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 14, 2024 · filing
  • Results announced
    Form 8-K · items 1.02, 2.02, 9.01 · filed Oct 10, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 14, 2024 · filing
  • Change of auditor
    Form 8-K · items 4.01, 9.01 · filed Jun 21, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 15, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Apr 1, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Feb 22, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jan 22, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01 · filed Jan 2, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Dec 28, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Dec 22, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Nov 15, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 14, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 2.02, 3.01, 9.01 · filed Nov 14, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 3.01, 9.01 · filed Nov 14, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Sep 28, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 14, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 14, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jul 5, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 10, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 10, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Mar 30, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 7, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 7, 2023 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jan 4, 2023 · filing